HighMark Wealth Management’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $31.1K | Buy |
77
+45
| +141% | +$18.1K | 0.02% | 196 |
|
|
2025
Q1 | $15.9K | Sell |
32
-5
| -14% | -$2.49K | 0.01% | 221 |
|
|
2024
Q4 | $19.3K | Sell |
37
-69
| -65% | -$35.9K | 0.01% | 201 |
|
|
2024
Q3 | $65.8K | Buy |
106
+7
| +7% | +$4.35K | 0.04% | 128 |
|
|
2024
Q2 | $55K | Buy |
99
+6
| +6% | +$3.33K | 0.03% | 129 |
|
|
2024
Q1 | $57.7K | Buy |
93
+2
| +2% | +$1.24K | 0.04% | 126 |
|
|
2023
Q4 | $48.5K | Sell |
91
-1
| -1% | -$533 | 0.04% | 134 |
|
|
2023
Q3 | $46.7K | Buy |
92
+5
| +6% | +$2.54K | 0.04% | 117 |
|
|
2023
Q2 | $43.9K | Buy |
87
+2
| +2% | +$1.01K | 0.03% | 126 |
|
|
2023
Q1 | $49.1K | Hold |
85
| – | – | 0.04% | 138 |
|
|
2022
Q4 | $46.9K | Sell |
85
-7
| -8% | -$3.86K | 0.04% | 107 |
|
|
2022
Q3 | $47K | Buy |
92
+2
| +2% | +$1.02K | 0.04% | 99 |
|
|
2022
Q2 | $49K | Buy |
90
+1
| +1% | +$544 | 0.04% | 105 |
|
|
2022
Q1 | $53K | Sell |
89
-16
| -15% | -$9.53K | 0.04% | 105 |
|
|
2021
Q4 | $70K | Buy |
105
+62
| +144% | +$41.3K | 0.04% | 98 |
|
|
2021
Q3 | $25K | Sell |
43
-4
| -9% | -$2.33K | 0.02% | 165 |
|
|
2021
Q2 | $23K | Hold |
47
| – | – | 0.02% | 171 |
|
|
2021
Q1 | $21K | Hold |
47
| – | – | 0.02% | 167 |
|
|
2020
Q4 | $22K | Buy |
47
+6
| +15% | +$2.81K | 0.02% | 158 |
|
|
2020
Q3 | $18K | Buy |
41
+3
| +8% | +$1.32K | 0.02% | 179 |
|
|
2020
Q2 | $14K | Sell |
38
-493
| -93% | -$182K | 0.02% | 164 |
|
|
2020
Q1 | $150K | Sell |
531
-19
| -3% | -$5.37K | 0.18% | 36 |
|
|
2019
Q4 | $178K | Buy |
+550
| New | +$178K | 0.19% | 38 |
|